Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Retrospective Analysis of Renal Function, Tac Dose Adjustments and CYP3A5 Pharmacogenetics in Stable Renal Transplant Recipients Converted From Tac BID to Tac OD

NCT01884480 is registered in ClinicalTrials.gov with Unity Health Toronto as lead sponsor.

NCT NCT01884480
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01884480 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Retrospective Analysis of Renal Function, Tac Dose Adjustments and CYP3A5 Pharmacogenetics in Stable Renal Transplant Recipients Converted From Tac BID to Tac OD
Lead sponsor
Unity Health Toronto
Phase
Observational
Overall status
Completed
Start date
June 30, 2013
Completion date
September 30, 2014
Enrollment
60 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

examin ethnicity and pharmacogenetics of the cohort requiring dose adjustment post-conversion, real function post conversion from prograf to advagraf